MedPath

Intrathecal Prilocaine and Adductor Canal Block vs Intrathecal Bupivacaine Alone for Ambulatory Knee Arthroscopy

Phase 4
Completed
Conditions
Post Operative Pain
Interventions
Drug: spinal anesthesia with bupivacaine
Drug: spinal anesthesia with hyperbaric prilocaine+adductor canal block (ACB) with bupivacaine
Registration Number
NCT05609565
Lead Sponsor
Ain Shams University
Brief Summary

- Although bupivacaine is safe and has a low rate of transient neurologic symptoms, the prolonged sensory and motor block is a drawback for day-case spinal anesthesia.Intrathecal hyperbaric prilocaine causes a much shorter motor block, with a similar onset time and lower inter-individual variability in motor block duration. Furthermore, the peripheral nerve block is used as an adjunct to the spinal anesthesia to prolong the surgical anesthetic conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) score I-II.
  • Body mass index < 35 kg/m2
Exclusion Criteria
  • Patient's refusal.
  • Known coagulopathy.
  • Known peripheral neuropathy or neurological deficits.
  • Known allergy to study drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2spinal anesthesia with bupivacaine-
Group 1spinal anesthesia with hyperbaric prilocaine+adductor canal block (ACB) with bupivacaine-
Primary Outcome Measures
NameTimeMethod
The duration of motor block (minutes)24 hours postoperatively

The duration of motor block (minutes)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain-Shams University Hospitals

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath